Correlation Between NewAmsterdam Pharma and Lipella Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both NewAmsterdam Pharma and Lipella Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NewAmsterdam Pharma and Lipella Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NewAmsterdam Pharma and Lipella Pharmaceuticals Common, you can compare the effects of market volatilities on NewAmsterdam Pharma and Lipella Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NewAmsterdam Pharma with a short position of Lipella Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of NewAmsterdam Pharma and Lipella Pharmaceuticals.
Diversification Opportunities for NewAmsterdam Pharma and Lipella Pharmaceuticals
-0.28 | Correlation Coefficient |
Very good diversification
The 3 months correlation between NewAmsterdam and Lipella is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding NewAmsterdam Pharma and Lipella Pharmaceuticals Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipella Pharmaceuticals and NewAmsterdam Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NewAmsterdam Pharma are associated (or correlated) with Lipella Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipella Pharmaceuticals has no effect on the direction of NewAmsterdam Pharma i.e., NewAmsterdam Pharma and Lipella Pharmaceuticals go up and down completely randomly.
Pair Corralation between NewAmsterdam Pharma and Lipella Pharmaceuticals
Given the investment horizon of 90 days NewAmsterdam Pharma is expected to under-perform the Lipella Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, NewAmsterdam Pharma is 8.21 times less risky than Lipella Pharmaceuticals. The stock trades about -0.34 of its potential returns per unit of risk. The Lipella Pharmaceuticals Common is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 272.00 in Lipella Pharmaceuticals Common on November 27, 2024 and sell it today you would earn a total of 28.00 from holding Lipella Pharmaceuticals Common or generate 10.29% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
NewAmsterdam Pharma vs. Lipella Pharmaceuticals Common
Performance |
| Timeline |
| NewAmsterdam Pharma |
| Lipella Pharmaceuticals |
NewAmsterdam Pharma and Lipella Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NewAmsterdam Pharma and Lipella Pharmaceuticals
The main advantage of trading using opposite NewAmsterdam Pharma and Lipella Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NewAmsterdam Pharma position performs unexpectedly, Lipella Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipella Pharmaceuticals will offset losses from the drop in Lipella Pharmaceuticals' long position.| NewAmsterdam Pharma vs. Monte Rosa Therapeutics | NewAmsterdam Pharma vs. Inventiva Sa | NewAmsterdam Pharma vs. Cullinan Oncology LLC | NewAmsterdam Pharma vs. Compass Therapeutics |
| Lipella Pharmaceuticals vs. Senti Biosciences | Lipella Pharmaceuticals vs. Fennec Pharmaceuticals | Lipella Pharmaceuticals vs. Monopar Therapeutics | Lipella Pharmaceuticals vs. Akeso, Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |